ID

38140

Beschrijving

Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01926964

Link

https://clinicaltrials.gov/show/NCT01926964

Trefwoorden

Versies (1)
  1. 21-09-19 21-09-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

21 september 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT01926964

Engels

Eligibility Breast Cancer NCT01926964

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients screening criteria
Beschrijving

Screening criteria

Datatype

boolean

Alias
UMLS CUI [1,1]
C1710032
UMLS CUI [1,2]
C0243161
1. ≥ 18 years old female patients.
Beschrijving

Age | Gender

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0079399
2. resected primary breast cancer (r0 resection).
Beschrijving

Excision Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0728940
UMLS CUI [1,2]
C0678222
3. er-positive breast cancer (defined as at least 10% er-positive malignant cells).
Beschrijving

Oestrogen receptor positive breast cancer

Datatype

boolean

Alias
UMLS CUI [1]
C2938924
4. her2 negativity by ihc (0 or 1+) or by fish (negative if ratio is ≤ 2.0).
Beschrijving

HER2 Negative Immunohistochemistry | HER2 Negative FISH

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348908
UMLS CUI [1,2]
C0021044
UMLS CUI [2,1]
C2348908
UMLS CUI [2,2]
C0162789
5. pn0 or pn1a (1-3 positive nodes) by sentinel procedure or axillary dissection.
Beschrijving

TNM Breast tumor staging | Number of Lymph Nodes Positive | Sentinel Lymph Node Biopsy | Excision of axillary lymph nodes

Datatype

boolean

Alias
UMLS CUI [1]
C0474926
UMLS CUI [2]
C4086646
UMLS CUI [3]
C0796693
UMLS CUI [4]
C0193867
all patients matching the screening criteria should be recorded consecutively in the patient screening and enrollment list.
Beschrijving

Screening criteria Fulfill | Enrollment

Datatype

boolean

Alias
UMLS CUI [1,1]
C1710032
UMLS CUI [1,2]
C0243161
UMLS CUI [1,3]
C1550543
UMLS CUI [2]
C1516879
patients inclusion criteria for baseline data collection
Beschrijving

Inclusion criteria Baseline Data Collection

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1442488
UMLS CUI [1,3]
C0010995
1. signed informed consent form for participation to the baseline data collection.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
in addition, the following information must be available from the pathology report:
Beschrijving

Availability of Information Pathology report

Datatype

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1533716
UMLS CUI [1,3]
C0807321
2. estimation of the pathologic maximum tumor diameter (in mm).
Beschrijving

Tumor Diameter Maximum

Datatype

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1301886
UMLS CUI [1,3]
C0806909
3. results of er positive tumor cells (in %) and of pgr positive tumor cells (in %) of the invasive component.
Beschrijving

Neoplastic Cell Estrogen receptor positive Percentage | Neoplastic Cell Progesterone receptor positive Percentage | Component Invasive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0597032
UMLS CUI [1,2]
C0279754
UMLS CUI [1,3]
C0439165
UMLS CUI [2,1]
C0597032
UMLS CUI [2,2]
C0279759
UMLS CUI [2,3]
C0439165
UMLS CUI [3,1]
C1705248
UMLS CUI [3,2]
C0205281
4. proliferation rate by ki-67 staining (mib-1 antibody) in %.
Beschrijving

Proliferation Rate Percentage Ki67 Staining Method | MIB-1 antibody

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514485
UMLS CUI [1,2]
C0871208
UMLS CUI [1,3]
C0439165
UMLS CUI [1,4]
C4055454
UMLS CUI [2]
C1138401
5. result of modified bloom-richardson-elston (bre) grading (grade 1, 2 or 3).
Beschrijving

Modified Bloom-Richardson-Elston grading system

Datatype

boolean

Alias
UMLS CUI [1]
C1527124
patients eligibility criteria for participation to the study inclusion criteria
Beschrijving

Eligibility Criteria | Participation Clinical Trial Inclusion criteria

Datatype

boolean

Alias
UMLS CUI [1]
C1516637
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C0008976
UMLS CUI [2,3]
C1512693
1. signed informed consent form for participation to the study sakk 26/10.
Beschrijving

Informed Consent | Participation Clinical Trial Specified

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C0008976
UMLS CUI [2,3]
C0205369
2. the patient is considered suitable to receive adjuvant chemotherapy (ie no medical contraindications to chemotherapy).
Beschrijving

Patients Appropriate Adjuvant Chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C0085533
3. invasive breast cancer tissue is available to prepare 39 sections (35 unstained + 4 h&e stained slides, thickness of 5 µm).
Beschrijving

Invasive carcinoma of breast | Availability of Tumor tissue sample | Section Quantity | Unstained Specimen | Hematoxylin and eosin stain method

Datatype

boolean

Alias
UMLS CUI [1]
C0853879
UMLS CUI [2,1]
C0470187
UMLS CUI [2,2]
C0475358
UMLS CUI [3,1]
C0700320
UMLS CUI [3,2]
C1265611
UMLS CUI [4]
C1883469
UMLS CUI [5]
C0523207
4. performance status: 0 or 1.
Beschrijving

Performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1518965
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. pregnancy
Beschrijving

Pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
2. bilateral invasive breast cancer
Beschrijving

Invasive carcinoma of breast Bilateral

Datatype

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0238767
3. ct4 and pt4 tumors.
Beschrijving

TNM Breast tumor staging

Datatype

boolean

Alias
UMLS CUI [1]
C0474926
4. patient with a current psychiatric or medical diagnosis that would interfere with her ability to participate in this study.
Beschrijving

Mental disorder Interferes with Study Subject Participation Status | Disease Interferes with Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2348568
5. known metastatic breast cancer (m1).
Beschrijving

Secondary malignant neoplasm of female breast

Datatype

boolean

Alias
UMLS CUI [1]
C0346993
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT01926964

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Screening criteria
Item
patients screening criteria
boolean
C1710032 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Age | Gender
Item
1. ≥ 18 years old female patients.
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Excision Breast Carcinoma
Item
2. resected primary breast cancer (r0 resection).
boolean
C0728940 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
Oestrogen receptor positive breast cancer
Item
3. er-positive breast cancer (defined as at least 10% er-positive malignant cells).
boolean
C2938924 (UMLS CUI [1])
HER2 Negative Immunohistochemistry | HER2 Negative FISH
Item
4. her2 negativity by ihc (0 or 1+) or by fish (negative if ratio is ≤ 2.0).
boolean
C2348908 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C2348908 (UMLS CUI [2,1])
C0162789 (UMLS CUI [2,2])
TNM Breast tumor staging | Number of Lymph Nodes Positive | Sentinel Lymph Node Biopsy | Excision of axillary lymph nodes
Item
5. pn0 or pn1a (1-3 positive nodes) by sentinel procedure or axillary dissection.
boolean
C0474926 (UMLS CUI [1])
C4086646 (UMLS CUI [2])
C0796693 (UMLS CUI [3])
C0193867 (UMLS CUI [4])
Screening criteria Fulfill | Enrollment
Item
all patients matching the screening criteria should be recorded consecutively in the patient screening and enrollment list.
boolean
C1710032 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C1516879 (UMLS CUI [2])
Inclusion criteria Baseline Data Collection
Item
patients inclusion criteria for baseline data collection
boolean
C1512693 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C0010995 (UMLS CUI [1,3])
Informed Consent
Item
1. signed informed consent form for participation to the baseline data collection.
boolean
C0021430 (UMLS CUI [1])
Availability of Information Pathology report
Item
in addition, the following information must be available from the pathology report:
boolean
C0470187 (UMLS CUI [1,1])
C1533716 (UMLS CUI [1,2])
C0807321 (UMLS CUI [1,3])
Tumor Diameter Maximum
Item
2. estimation of the pathologic maximum tumor diameter (in mm).
boolean
C0027651 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
Neoplastic Cell Estrogen receptor positive Percentage | Neoplastic Cell Progesterone receptor positive Percentage | Component Invasive
Item
3. results of er positive tumor cells (in %) and of pgr positive tumor cells (in %) of the invasive component.
boolean
C0597032 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0597032 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
C1705248 (UMLS CUI [3,1])
C0205281 (UMLS CUI [3,2])
Proliferation Rate Percentage Ki67 Staining Method | MIB-1 antibody
Item
4. proliferation rate by ki-67 staining (mib-1 antibody) in %.
boolean
C1514485 (UMLS CUI [1,1])
C0871208 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C4055454 (UMLS CUI [1,4])
C1138401 (UMLS CUI [2])
Modified Bloom-Richardson-Elston grading system
Item
5. result of modified bloom-richardson-elston (bre) grading (grade 1, 2 or 3).
boolean
C1527124 (UMLS CUI [1])
Eligibility Criteria | Participation Clinical Trial Inclusion criteria
Item
patients eligibility criteria for participation to the study inclusion criteria
boolean
C1516637 (UMLS CUI [1])
C0679823 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C1512693 (UMLS CUI [2,3])
Informed Consent | Participation Clinical Trial Specified
Item
1. signed informed consent form for participation to the study sakk 26/10.
boolean
C0021430 (UMLS CUI [1])
C0679823 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
Patients Appropriate Adjuvant Chemotherapy
Item
2. the patient is considered suitable to receive adjuvant chemotherapy (ie no medical contraindications to chemotherapy).
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
Invasive carcinoma of breast | Availability of Tumor tissue sample | Section Quantity | Unstained Specimen | Hematoxylin and eosin stain method
Item
3. invasive breast cancer tissue is available to prepare 39 sections (35 unstained + 4 h&e stained slides, thickness of 5 µm).
boolean
C0853879 (UMLS CUI [1])
C0470187 (UMLS CUI [2,1])
C0475358 (UMLS CUI [2,2])
C0700320 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1883469 (UMLS CUI [4])
C0523207 (UMLS CUI [5])
Performance status
Item
4. performance status: 0 or 1.
boolean
C1518965 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy
Item
1. pregnancy
boolean
C0032961 (UMLS CUI [1])
Invasive carcinoma of breast Bilateral
Item
2. bilateral invasive breast cancer
boolean
C0853879 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
TNM Breast tumor staging
Item
3. ct4 and pt4 tumors.
boolean
C0474926 (UMLS CUI [1])
Mental disorder Interferes with Study Subject Participation Status | Disease Interferes with Study Subject Participation Status
Item
4. patient with a current psychiatric or medical diagnosis that would interfere with her ability to participate in this study.
boolean
C0004936 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
Secondary malignant neoplasm of female breast
Item
5. known metastatic breast cancer (m1).
boolean
C0346993 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial